Home > News > Academic Conference

Academic Conference

KingMed Diagnostics (Hong Kong) Hosted Successfully Lp-PLA2 Symposium

Published:[2013-08-16]

 

On August 16, 2013, Lp-PLA2 Symposium sponsored by KingMed Diagnostics (Hong Kong) was held successfully in CARNEVINO Hotel in central, Hong Kong. The meeting was chaired by Mr. Yang Zhenqiu, the general manager and laboratory director of KingMed Diagnostics (Hong Kong) while Professor Aoton Jansen from DiaDexus, the executive team in USA, was invited to give instruction in the meeting.
 

At the meeting, Professor Aoton Jansen noted that the lipoprotein-associated phospholipase A2 has been attracted broad attention in the medical community in recently years. As a new inflammatory enzyme found in cardiovascular diseases which can generate the Lyso-PC and ox-FA, and facilitate the formation and development of atherosclerosis through the hydrolysis-oxidation of low-density lipoprotein (LDL), its relationship with the clinical diseases has been drawn gradually more attention. The increase of Lp-PLA2 level predicts the high risk of formation and rupture of plaques while it can be used solely to forecast the occurrence of cardiovascular and cerebrovascular diseases.
 

As the first third-party medical testing institution which develops Lp-PLA2 (lipoprotein-associated phospholipase A2) testing item in Hong Kong and even in China, KingMed Diagnostics (Hong Kong) will provide the more professional services for the medical institutions in Hong Kong and mainland by introducing the advanced foreign technology.